Physician profile
Anne Jeffries
NPI 1649385261
$849.28
in general payments reported to CMS, 2019-2025
11 companies · $533 in 2025
The $533 reported for 2025 was more than what 96% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.33 · 2022: $144 · 2023: $155 · 2024: $5.61 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $204.90 | 2023-2025 | Veozah |
| Biogen, INC. | $202.50 | 2025 | Zurzuvae |
| Lilly USA, LLC | $123.97 | 2022 | |
| Amgen INC. | $121.84 | 2025 | Evenity |
| Mayne Pharma Commercial LLC | $41.12 | 2025 | |
| Organon LLC | $39.08 | 2024-2025 | Jada System |
| Coopersurgical, INC. | $32.09 | 2023 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Abbvie INC. | $27.67 | 2021-2025 | |
| Optumhealth Care Solutions, LLC | $21.70 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pacira Pharmaceuticals Incorporated | $20.07 | 2022 | |
| Exeltis, USA INC. | $14.34 | 2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Jeffries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.